Healthleap Secures $38 Million to Advance AI-Driven Patient Risk Detection in Hospitals
Healthleap, a promising startup focused on leveraging artificial intelligence to analyze patient records and identify those at risk of undiagnosed illnesses, has successfully raised $38 million through seed and Series A funding rounds, according to an exclusive report by TechCrunch.
This recent financing round includes an $8 million seed investment co-led by renowned venture firms Sequoia Capital and First Round Capital, alongside a $30 million Series A round spearheaded by Hummingbird Ventures. While the company has opted not to disclose its current valuation, the capital influx underscores growing confidence in Healthleap’s innovative approach to hospital patient care.
From Clinical Nutrition to Broad AI-Driven Risk Identification
Founded in South Africa in 2022 by siblings Jemima and Josiah Meyer, Healthleap began its journey by offering a clinical nutrition tool designed specifically for dietitians. Jemima Meyer originally crafted this solution, aiming to improve nutritional assessments in clinical settings. However, as the startup evolved, it pivoted towards a more expansive platform capable of detecting a range of underdiagnosed conditions in hospitalized patients, including malnutrition and delirium, Josiah Meyer, CEO and co-founder, explained to TechCrunch.
“A patient’s chart holds two kinds of data. Labs, weights, and vital signs sit in structured fields, but the most telling signs sit in clinicians’ written notes: poor appetite, recent weight loss, muscle loss, trouble swallowing. Our developing approach is extracting affirmative or negated mentions of these clinical concepts in an easily extensible and scalable way,” Josiah noted.
Currently, Healthleap’s platform is deployed in over 50 hospitals, screening patients for conditions such as malnutrition and delirium. The company is also developing models to identify aspiration pneumonia, pressure ulcers, and risks of readmission for congestive heart failure, all undergoing rigorous clinical validation.
How Healthleap’s AI Platform Works
Healthleap’s technology integrates directly with hospitals’ electronic health record (EHR) systems, using advanced language models to extract critical clinical insights from unstructured data such as doctors’ notes. These insights—like mentions of recent weight loss or swallowing difficulties—are combined with structured data including lab results and vital signs to generate risk scores. These scores help care teams prioritize patients who may require additional attention, although the software itself does not provide diagnoses.
“Each night, we analyze every adult inpatient’s record: lab results, vital signs, weights, medications, diet orders, diagnoses, clinicians’ notes, and more,” Josiah explained. “Each morning, we write a risk score into the care team’s existing workflow with a dashboard accessible that holds additional information about the patients’ trends.”
Addressing the Critical Issue of Undiagnosed Malnutrition
Malnutrition presents a particularly impactful use case for Healthleap’s platform. It is a condition that often goes undetected yet significantly impairs patient recovery. Research indicates that between 20% to 50% of hospital inpatients suffer from malnutrition, with studies linking it to longer hospital stays, impaired wound healing, infections, and increased morbidity and mortality (source, source, source).
Since its inception, Healthleap has expanded its hospital partnerships from three to over 50, counting major health systems such as Penn Medicine, Cedars-Sinai, Intermountain Healthcare, Houston Methodist, and Emory Healthcare among its customers. The company reports revenue growth exceeding tenfold within the past year, although specific figures remain undisclosed.
Proven Financial Impact and Outcome-Based Pricing
Healthleap’s business model involves three-year contracts priced based on the number of licensed beds in a hospital, complemented by an outcome-based pricing structure. This model ties payment to measurable returns on investment (ROI), validated by hospital finance teams. According to Josiah Meyer, every customer has experienced at least a 5x ROI, with some achieving upwards of 20x annual total ROI.
One notable example is the Hospital of the University of Pennsylvania, where Healthleap’s malnutrition program generated an annualized financial impact of $23.8 million—$6.3 million from additional reimbursement and $17.5 million from shortened hospital stays.
Future Plans: Expanding Capabilities and Care Settings
With the new funding, Healthleap intends to invest in engineering, product development, sales, and customer success teams. The company plans to broaden its platform to cover more than 40 major health conditions and aims to extend its reach beyond inpatient settings into outpatient and home care environments.
This strategic expansion reflects Healthleap’s ambition to become a comprehensive AI-powered partner in healthcare, helping clinicians and care teams identify at-risk patients earlier and improve health outcomes across diverse care settings.
When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.
Source: Here
